Ignore Short-Term Growth Troubles And Buy AstraZeneca plc, Halfords Group plc & Ultra Electronics Holdings plc!

Royston Wild explains why the earnings outlook remains compelling at AstraZeneca plc (LON: AZN), Halfords Group plc (LON: HFD) and Ultra Electronics Holdings plc (LON: ULE).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at three growth laggards that should deliver brilliant returns for patient stock selectors.

AstraZeneca

Thanks to the enduring problem of patent expirations, the bottom-line at AstraZeneca (LSE: AZN) is not expected to enjoy a sudden upsurge any time soon. With blockbusting labels like Crestor and Nexium falling prey to rising competition from generic substitutes, the City expects revenues to fall again in 2015 and 2016 respectively, pushing earnings fractionally lower this year and by 4% in the following period.

On top of this, AstraZeneca is also having to splash out vast sums to resuscitate its product pipeline and offset these troubles — total R&D spend during January-June rose by almost a quarter, to $2.64bn. Still, I believe that long-term investors should be encouraged by the progress the Cambridge firm is making to deliver the next generation of sales drivers.

AstraZeneca currently has 15 new molecular entities (or NMEs) under regulatory review or at the ‘pivotal study’ stage, with several in the critical growth areas of Respiratory and Oncology. And the business expects 8-10 NMEs and product extensions to receive regulatory approval this year and next. With the pharma play also pulling up trees in emerging markets, and embarking on a huge lab-building programme across the US and Europe, I believe a P/E ratio of 15.9 times for 2015 represents a great point to get in on AstraZeneca’s excellent long-term growth prospects.

Halfords Group

Market appetite for bike and car services giant Halfords (LSE: HFD) has fallen off a cliff during the past couple of months. The business is now dealing at a 21% discount to levels seen at the start of August, a combination of heavy profit-booking after recent heady gains and a ghoulish trading statement keeping potential buyers away.

Halfords announced that underlying cycle sales slumped 11% in the eight weeks to the close of August, a result that pushed total like-for-like sales 1.3% lower. However, this revenues blip should be considered in the wider context of stunning bike sales in the past couple of years, while the retailer’s position as the premier destination for automotive parts and services was once again highlighted — underlying revenues at its Car Maintenance and Car Enhancement divisions advanced 7.3% and 4.7% respectively in the period.

The City expects Halfords to record a 1% earnings decline in the 12 months to March 2016, resulting in a very decent P/E multiple of 13.5 times. But thanks to the huge investment being made in its brands, not to mention the impact of store refurbishments and improvements to its online presence, the retailer is expected to enjoy a 7% bottom-line bump in 2017, pushing the ratio to an even-better 12.6 times.

Ultra Electronics Holdings

Like Halfords, defence play Ultra Electronics (LSE: ULE) has seen its share price erode more recently and the business has conceded 9% during the past three weeks alone. However, I believe this represents a solid entry point as improving economic conditions from key Western customers drive demand for its high-tech gear.

The Greenford firm saw revenues slide 2.7% during January-June, to £331.7m, caused predominantly by the termination of a contract to update IT systems at Oman Airport. Still, Ultra Electronics expects performance to pick up during the second half of 2015, and I believe the company’s expertise in hot growth areas like cyber security should pay off handsomely looking even further down the line.

On top of this, Ultra Electronics also has an appetite to boost growth through shrewd acquisitions — just last month the firm snapped up the electronics division of Kratos Defense & Security Solutions for $265m, giving its Communications & Security arm further fuel. Against this backcloth the number crunchers expect Ultra Electronics to bounce from a 3% earnings decline this year and record an 8% increase in 2016, figures that create handsome P/E ratios of 13.9 times and 12.7 times correspondingly.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »